Author

Timothy Hoops 1

1 Janssen Scientific Affairs, LLC,Horsham,United States

GASTROINTESTINAL SYMPTOMS ARE COMMON IN U.S. PATIENTS WITH MODERATE-SEVERE PSORIASIS

Steven Feldman, Steve Fakharzadeh, Jill Abell, Timothy Hoops, Bhaskar Srivastava, Erik Muser, Danielle Dungee, Sean Quinn, Megan Leone-Perkins, Michael Kappelman

GASTROINTESTINAL SYMPTOMS ARE COMMON IN U.S. PATIENTS WITH MODERATE-SEVERE PSORIASIS

Timothy Hoops

HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY

Christopher Gasink, Edward V. Loftus Jr, Timothy Hoops, James Izanec, Tony Ma, Zhijie Ding, Erik Muser, Peter Irving, Matthieu Allez, William J. Sandborn, Remo Panaccione, Silvio Danese

HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: PROMIS-29 IN THE SEAVUE STUDY

Matthieu Allez, James D. Lewis, Peter Irving, Timothy Hoops, James Izanec, Tony Ma, Zhijie Ding, Erik Muser, Christopher Gasink, Remo Panaccione, Edward V. Loftus Jr, Bruce E. Sands, Silvio Danese

USTEKINUMAB IV INDUCTION RESULTS IN CROHN’S DISEASE SYMPTOM IMPROVEMENT WITHIN THE FIRST WEEK IN ANTI-TNF REFRACTORY PATIENTS    

William Sandborn, Benjamin Yeager, Christopher Gasink, Timothy Hoops, Long-Long Gao, Yanli Wang, Douglas Jacobstein, Scott D. Lee, Stephen B Hanauer

Item 1 - 5 / 5
1